Your browser doesn't support javascript.
loading
Biliary tract cancers: SEOM clinical guidelines
Benavides, M; Antón, A; Gallego, J; Gómez, MA; Jiménez-Gordo, A; La Casta, A; Laquente, B; Macarulla, T; Rodríguez-Mowbray, JR; Maurel, J.
Affiliation
  • Benavides, M; Hospital Universitario Regional y Virgen de la Victoria. Málaga. Spain
  • Antón, A; Hospital Universitario Miguel Servet. Zaragoza. Spain
  • Gallego, J; Hospital General Universitario. Elche. Spain
  • Gómez, MA; Hospital Universitario Reina Sofía. Córdoba. Spain
  • Jiménez-Gordo, A; Hospital Universitario Infanta Sofía. San Sebastián de los Reyes. Spain
  • La Casta, A; Hospital Universitario Donostia. San Sebastián. Spain
  • Laquente, B; Institut Catala d’Oncologia. L’Hospitalet. Spain
  • Macarulla, T; Hospital Universitario Vall d’Hebron. Instituto de Oncología Vall d’Hebron. Barcelona. Spain
  • Rodríguez-Mowbray, JR; Hospital Infanta Cristina. Badajoz. Spain
  • Maurel, J; Hospital Clínic. Barcelona. Spain
Clin. transl. oncol. (Print) ; 17(12): 982-987, dic. 2015. tab, ilus
Article in English | IBECS | ID: ibc-147436
Responsible library: ES1.1
Localization: BNCS
ABSTRACT
Biliary tract cancer (BTC) is an uncommon and highly fatal malignancy. It is composed of three main different entities; Gall bladder carcinoma (GBC), intrahepatic cholangiocarcinoma (iCC) and extrahepatic cholangiocarcinoma (eCC) sharing different genetic, risk factors and clinical presentation. Multidetector-row computed tomography (MDCT) and magnetic resonance cholangio-pancreatography (MRCP) are the more important diagnostic techniques. Surgery is the only potentially curative therapy but disease recurrence is frequent. Treatment with chemotherapy, radiotherapy or both has not demonstrated survival benefit in the adjuvant setting. Cisplatin plus gemcitabine constitutes the gold standard in metastatic disease. New ongoing studies mainly in the adjuvant and neoadjuvant setting along with molecular research will hopefully help to improve survival and quality of life of this disease (AU)
RESUMEN
No disponible
Subject(s)
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Biliary Tract Neoplasms / Urinary Bladder Neoplasms / Magnetic Resonance Spectroscopy / Tomography / Cholangitis / Cholangiocarcinoma Type of study: Diagnostic study / Practice guideline / Risk factors Aspects: Patient-preference Limits: Female / Humans / Male Language: English Journal: Clin. transl. oncol. (Print) Year: 2015 Document type: Article Institution/Affiliation country: Hospital Clínic/Spain / Hospital General Universitario/Spain / Hospital Infanta Cristina/Spain / Hospital Universitario Donostia/Spain / Hospital Universitario Infanta Sofía/Spain / Hospital Universitario Miguel Servet/Spain / Hospital Universitario Regional y Virgen de la Victoria/Spain / Hospital Universitario Reina Sofía/Spain / Hospital Universitario Vall d’Hebron/Spain / Institut Catala d’Oncologia/Spain
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: Available Collection: National databases / Spain Database: IBECS Main subject: Biliary Tract Neoplasms / Urinary Bladder Neoplasms / Magnetic Resonance Spectroscopy / Tomography / Cholangitis / Cholangiocarcinoma Type of study: Diagnostic study / Practice guideline / Risk factors Aspects: Patient-preference Limits: Female / Humans / Male Language: English Journal: Clin. transl. oncol. (Print) Year: 2015 Document type: Article Institution/Affiliation country: Hospital Clínic/Spain / Hospital General Universitario/Spain / Hospital Infanta Cristina/Spain / Hospital Universitario Donostia/Spain / Hospital Universitario Infanta Sofía/Spain / Hospital Universitario Miguel Servet/Spain / Hospital Universitario Regional y Virgen de la Victoria/Spain / Hospital Universitario Reina Sofía/Spain / Hospital Universitario Vall d’Hebron/Spain / Institut Catala d’Oncologia/Spain